Capacity building in combining targeted prevention with meaningful HIV surveillance among MSM

Size: px
Start display at page:

Download "Capacity building in combining targeted prevention with meaningful HIV surveillance among MSM"

Transcription

1 Capacity building in combining targeted prevention with meaningful HIV surveillance among MSM Global AIDS Response Progress Reporting GARPR indicators in Barcelona, Bratislava, Brighton, Brussels, Bucharest, Hamburg, Lisbon, Ljubljana, Sofia, Stockholm, Verona, Vilnius, and Warsaw among MSM This document is based on data from the Sialon II project, funded under the European Commission s (EC) Public Health Programme (Work Plan 2010). The sole responsibility lies with the authors of this report and the Commission is not responsible for any use that may be made of the information contained therein 1

2 SIALON II project summary In line with the last Communication on combating HIV/AIDS in the European Union and neighbouring countries ( ) 1, the overall objective of this project was to carry out and promote combined and targeted prevention complemented by a meaningful surveillance among MSM. More specifically, the aim was to develop capacity building and know-how through both training and on-site coaching under the active supervision of, and in collaboration with, the ECDC, WHO and UNAIDS on: i) prevention needs assessment and prevention actions, and; ii) innovative surveillance methodologies for hard to reach populations such as MSM (Time Location Sampling, Respondent Driven Sampling, HIV and STI testing). The SIALON II project was implemented using the same methodologies as defined by WHO/UNAIDS and ECDC (research protocols, GARPR/ECDC indicators, epidemiological algorithms) and prevention strategies across the participating countries. SIALON II was funded under the European Commission s (EC) Public Health Programme (Work Plan 2010). Background The project s strategic relevance lies in the fact that it addresses the need for an effective response in priority regions such as the EU Member States most affected by HIV. In line with the Health Programme 2010 Work Plan objective, SIALON II targeted MSM as one of the most at risk populations with the active involvement and participation of gay communities in all phases of the project actions. This included the development and implementation of targeted, culturally sensitive strategies of communication for the prevention of HIV and promotion of Voluntary Counselling and Testing (VCT) among MSM. Moreover, the project was in line with the implementation of the WHO and UNAIDS recommendations on Second Generation Surveillance Systems (SGSS), where the collection of behavioural and biological data as well the assessment of prevention needs are foreseen. Methods and means Formative research was carried out in each participating country in order to collect information on the local contexts and for assessing the prevention needs of MSM (Work Package 4). Data collectors (recruited through gay associations / NGOs) were trained locally on prevention issues using a jointly developed prevention protocol adopting a theory-based approach (i.e. the Minority-stress model 2 and the Information-Behavioural Skills model 3 ). Prevention activities were carried out concomitantly to data collection in community-based settings in the context of a broader prevention campaign supported by the project s website featuring gay-friendly services. The Sialon II prevention campaign consisted of a standardised approach to community-based prevention activities that were delivered during data collection, i.e. a community-based settings approach, which has inherent limitations in terms of what prevention can realistically achieve in venue-based settings. The tailored prevention activities included: (a) dissemination of prevention packages during data collection (containing 1 Communication from the Commission to the European Parliament, the Council, the European economic and social Committee and the Committee of the Regions. Combating HIV/AIDS in the European Union and neighbouring countries, , {SEC(2009) 1403}, {SEC(2009) 1404}, {SEC(2009) 1405}. Available at: 2 Meyer IH Minority stress and mental health in gay men. J Health Soc Behav Mar;36(1): Fisher, J.D. & Fisher, W.A. (1992). Changing AIDS-risk behaviour. Psychological Bulletin, 111,

3 condoms, lubricants), and distribution of leaflets with specifically tailored information; (b) interactive peer-to-peer health education activities delivered when recruiting study participants (this included using an interactive quiz to increase information on HIV and other STIs and promotion of HIV testing in a playful way). In addition, at RDS data collection sites, individual HIV-test counselling was conducted, promoting collection of test-results and linkage to care. These activities focused on improving knowledge and building motivation for safer-sex and uptake of HIV-testing among the participants (WP8). The project website supported the prevention activities by featuring gay-friendly services in selected study sites (through providing links to local community-based organisations). A bio-behavioural survey (WP5-WP6) was then implemented using standardised procedures for data collection in community-based settings. The Time-Location Sampling method (TLS) was adopted in nine countries including: Belgium, Bulgaria, Germany, Poland, Portugal, Slovenia, Spain, Sweden, and the UK. The Respondent-Driven Sampling (RDS) method was implemented in four countries including: Italy, Lithuania, Romania, and the Slovak Republic. In the latter settings, prevention activities focused additionally on sexual health promotion in the context of VCT and linkage to care. Data on MSM related prevention needs and behaviour were collected through an anonymous questionnaire linked to biological samples (serum for RDS countries and oral fluid for TLS countries). When needed, an online training programme was provided for laboratory technicians on testing (virology) at country level. Standardised testing procedures were implemented in each site for laboratory data analysis (WP7). An aliquot of HIV positive serum samples (only for countries where the RDS method was implemented) was then sent to a specialised laboratory for the calculation of HIV antibodies avidity index, and incidence estimation. Data were analysed in line with the GARPR indicators guidelines 4. Prior to any data collection, approval from all partners ethics and governance committees were obtained. The SIALON II research protocols were also approved by the WHO Research Project Review Panel (RP2-WHO) and by the Research Ethics Review Committee (WHO-ERC) in February Outcomes The project's results feed directly into HIV-related public health and health promotion practice and policy. Moreover, through the implementation of the project s processes, capacity has been built for all partners and their networks for both venue-based bio-behavioural surveillance and targeted prevention activities. This was achieved through expert training, coaching and the adoption of participatory approaches, and interactive dissemination methods. In concrete figures, a total of 99 trained data collectors/outreach prevention workers from 18 local prevention organisations disseminated about 9000 prevention packages and 3000 leaflets. About 1500 scratch-cards were used during prevention activities to sensitize MSM in the venues. Preliminary findings of the study were discussed with all partners involved in the preventionand data collection activities at a community-based prevention meeting. This has translated into a sustainable prevention outcome as partners have been able to utilise the results in their own prevention activities. Prevention initiatives have been taken over by local NGOs, such as 4 Global Aids Response Progress Reporting Construction of Core indicators for monitoring the United Nations Political declaration on HIV and Aids, Available at: 3

4 the continued condom-distribution, the continued use of prevention material produced within Sialon II, the initiation of rapid HIV testing in Bratislava, the creation of local NGO prevention networks, and the extension of office hours at HIV-testing sites to reduce thresholds (as in the case of Warsaw). In total, 14 such new prevention activities were reported by the partners of the Sialon II network. In addition, the involvement of the ECDC, WHO and UNAIDS has brought substantial added value to the project and has been directly and effectively connected to practical use of the research results. Finally, the use of outreach strategies and complementary methodologies maximised the validity and effectiveness of preventive interventions. In terms of project deliverables, specific reports have been produced including: a formative research report with information on target group characteristics, social contexts and prevention practices and gaps across the different study sites; a manual for data collection and surveillance among MSM; a prevention report describing the prevention activities that were conducted, lessons learned and major challenges to prevention activities. This report also includes examples of practice-based evidence of HIV/STI prevention and sexual health promotion targeting MSM; a summary report on the findings from the bio-behavioural surveys conducted via TLS and RDS (in press). In conclusion, the SIALON II project has contributed to the harmonisation of surveillance methodologies, and generated comparable data on behavioural and epidemiological indicators for MSM communities (ECDC and GARPR indicators). In doing so, the project has identified unmet prevention needs through the formative research conducted, and built communitybased capacity to carry out research and prevention in venue-based settings. While the Sialon II prevention campaign was designed to take place in the context of the TLS and RDS data collection venues, implementation of prevention activities went beyond the data collection as such. The project s close ties with local implementers of prevention activities have contributed to the sustainability of the project. Sialon II adopted a community-based, participatory approach throughout the whole project, which contributed to identify the shortcomings of existing prevention policies and measures (see also the Sialon II prevention report for more information), and strengthened a Europe-wide network of international (UNAIDS, WHO) and European (European Commission, ECDC) organisations, National Institutes of Public Health, Universities, and civil society organisations (NGOs working with and for MSM). Partners Main Partner AOUI Azienda Ospedaliera Universitaria Integrata Verona Italy Associated Partners IGTIP Fundació Institut d'investigació en Ciències de la Salut Germans Trias i Pujol, ICO - Institut Catala d'oncologia, Barcelona Spain INBI Institutul National De Boli Infectioase Prof. Dr. Matei Balș Bucharest Romania ACCEPT, LBGT NGO, Bucharest Romania IHMT/UNL Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa - Portugal ISS Istituto Superiore di Sanità, Rome Italy ITG Prins Leopold Instituut voor Tropische Geneeskunde, Antwerpen Belgium NCIPD National Centre of Infectious and Parasitic Diseases, Sofia - Bulgaria NIJZ National Institute of Public Health, Ljubljana Slovenia 4

5 NIZP-PZH - National Institute of Public Health - National Institute of Hygiene Warszawa Poland RKI - Robert Koch-Institut, Berlin - Germany Folkhälsomyndigheten Public Health Agency of Sweden, Stockholm Sweden SMU - Slovak Medical University, Bratislava - Slovakia ULAC - Centre for Communicable Diseases and AIDS, Vilnius - Lithuania UOB - University of Brighton, Brighton United Kingdom Collaborating Partners ECDC World Health Organisation UNAIDS London School of Hygiene and Tropical Medicine Local NGO s in different participating countries Contacts Massimo Mirandola (project coordinator): massimo.mirandola@ospedaleuniverona.it - Infectious Diseases Section - Department of Pathology - University Hospital; Lorenzo Gios (project manager): lorenzo.gios@ospedaleuniverona.it - CReMPE - Regional Coordination Centre for European Project Management, Veneto Region - Department of Health, C/O The Verona University Hospital, p.le Aristide Stefani Verona (VR) Italy, Tel: fax Website: 5

6 The SIALON II surveys Data collection was conducted in 2013 for the TLS arm of the project, and in 2014 for the RDS arm. The table 1 below presents the overall number of MSM enrolled in the study across countries according to the specific sampling method adopted for each study site. All estimates were calculated using specialised survey software and sampling weights. According to the GARP reporting guidelines, estimates should be reported disaggregated by age ( 25 and 25). Thus, the indicators below are reported by city as global estimates and disaggregated by both city and age. The age distribution of samples varied across the cities. Table 1.0: MSM enrolled in the study by city Sampling method City and Country Overall sample Time-Location Sampling Brussels, Belgium 406 (TLS) Sofia, Bulgaria 411 Hamburg, Germany 408 Warsaw, Poland 408 Lisbon, Portugal 409 Ljubljana, Slovenia 416 Barcelona, Spain 408 Stockholm, Sweden 377 Respondent-Driven Sampling (RDS) Brighton, UK 418 Verona, Italy 400 Vilnius, Lithuania 322 Bratislava, Slovakia 400 Bucharest, Romania 183 TOTAL SIALON II survey data Indicator Men who have sex with men: prevention programmes (percentage of men who have sex with men reached with HIV prevention programmes) This indicator is measured using two questions: one on knowledge regarding HIV testing facilities and the other on whether free condoms have been received over the last 12 months. Only positive answers to both questions were considered valid for the inclusion in the numerator of the indicator. In the TLS-cities, more than half of the men answered yes to both questions in all cities with the exception of Warsaw where less than one third of the participants answered yes to both questions. Conversely, less than half of the men in the RDScities answered yes to both questions, with the exception of men aged 25 years in Bucharest and men younger than 25 in Vilnius. The highest proportions were seen in Sofia and Hamburg with more than 80% reached through HIV prevention programmes. The lowest levels reached through HIV prevention programmes were seen in Bratislava and Warsaw with less than 30%. 6

7 In all thirteen cities (except Brighton, Hamburg, and Lisbon) men aged 25 years were reached to a higher extent compared with younger men ( 25 years) despite the differences between the age groups being small in most cities. Most men (>80%) in the survey reported knowing where to go to get an HIV test. However, there were differences between the age groups indicating that in general, men younger than 25 years are less aware about where to go for an HIV test. In young men aged 25 years, 80 90% reported knowing where to go. In two cities, Brighton, and Ljubljana, the proportions knowing where to go were higher in this age group (>92%). In men aged 25 years, 90% or more in all cities reported knowing where to get an HIV test. Most men report having been given condoms as part of HIV prevention activities during the last 12 months, except in Bratislava, Warsaw, and Verona. In these three cities, less than half of men (regardless of age) reported being given condoms. In the other cities for men aged 25 years, variations were observed ranging from 51% (CI 95% ) in Ljubljana to 95% (CI 95% ) in Sofia. For men aged 25 years, the highest proportions reporting having received condoms as part of HIV prevention activities during the last 12 months were seen in Hamburg and Sofia with 94% (CI 95% ) and 86% (CI 95% ) respectively. The lowest proportions were seen in Bratislava and Verona with 24.4% (CI 95% ) and 29.2% (CI 95% ) respectively. Differences were evident between the participating cities when comparing the type of venues and settings where men had been given condoms. In Sofia, Barcelona, Brussels, Lisbon, and Vilnius, the most common venues where men received condoms included saunas and night clubs/discos. For Hamburg, Bucharest, Verona, and Warsaw, outreach services and gay organisations were the most common channel for receiving condoms. Table 1.11 Weighted percentage of MSM having been reached by prevention programmes, 95% confidence intervals, design effect and number of participants, by city and age group (GARPR 1.11). In most cities, HIV prevalence was higher among BARCELONA BRATISLAVA Age BRIGHTON Point Estimate 95% Lower Bound 95% Upper Bound Estimated Design Effect Sample Size

8 BRUSSELS BUCHAREST HAMBURG LISBON LJUBLJANA SOFIA STOCKHOLM VERONA

9 VILNIUS WARSAW Indicator Men who have sex with men: condom use (percentage of men reporting the use of a condom the last time they had anal sex with a male partner) Condom use during last anal sex ranged between 68.7% in Barcelona to 45.2% in Bratislava. In most cities, higher proportions of condom use were reported by men aged 25 years. Exceptions were noted in Bratislava, Bucharest, Lisbon, Verona, and Warsaw. Variability was larger in men aged 25 years: condom use was reported by 84.6% of young MSM in Barcelona and 34.6% in Bucharest. In men aged 25 years, proportions varied between 72.0% in Lisbon to 46.7% in Bratislava. However, the small sample sizes for the younger age group in many of the study cities should be considered when interpreting these findings. Differences between cities can be explained partly by different proportions of men having their last anal intercourse with a steady partner. Condom use was much lower when the last anal sex partner was a steady partner compared to a non-steady partner. Condom use during last anal sex when the partner was the steady partner and the respondent was younger than 25 years was high in Brussels (60%), Sofia (63%) and Barcelona (69%), and low in Hamburg (26%) and Ljubljana (25%). Among older respondents with steady partners condom use increased among men from Warsaw, Lisbon, Ljubljana, and Stockholm. Condom use declined in older men from Brussels, Sofia, Hamburg, Barcelona, and Brighton. When the last anal sex partner was a non-steady partner, condom use during the last anal sex episode was generally high. Condom use with non-steady partners was usually higher among respondents aged 25 years than in respondents aged 25 years. Sexual roles during last anal intercourse were distributed equally between insertive, receptive, and both (versatile), with only minor variations between cities. Considering the last steady anal sex partner, serosorting with a presumed HIV serostatus -concordance between partners was reported very frequently in all cities. However, a lack of knowledge of the partner s sero-status was reported most frequently in Central European cities. HIV serostatus concordance before sex with non-steady anal sex partners was rarely established across all cities. 9

10 Table 1.12 Weighted percentage of MSM reporting condom use during last anal intercourse with a male partner, independent of type of partner, 95% confidence intervals, design effect and number of participants, by city and age group (GARPR 1.12). In most cities, HIV prevalence was higher among Age Point Estimate 95% Lower Bound 95% Upper Bound Estimated Design Effect Sample Size < BARCELONA BRATISLAVA BRIGHTON < < BRUSSELS BUCHAREST HAMBURG < < < LISBON <

11 LJUBLJANA < < SOFIA STOCKHOLM VERONA VILNIUS < < < < WARSAW Indicator 1.13 HIV testing in men who have sex with men (percentage of men who have sex with men who received an HIV test in the past 12 months and know their results) HIV testing over the last 12 months period and the collection of the test result is an important indicator to be used for monitoring testing and counselling availability. At city level, the indicator ranged from 37% in Bratislava to 74% in Sofia. Using the estimates of this composite indicator, it is possible to aggregate the cities into two main groups: testing rates under 50% (Bratislava, Brighton, Bucharest, Ljubljana, Verona, and Vilnius) and above 50% (Barcelona, Brussels, Hamburg, Lisbon, Sofia, Stockholm, and Warsaw). Considering the age disaggregation, in Brighton, Brussels, and Warsaw more than 50% of the older men ( 25 years) 11

12 reported a known HIV test within the last 12 months while among the younger men ( 25 years) it was less than 50%. In Lisbon only 21% of the younger men reported a known HIV test over the last 12 month period, which represents the lowest level in the study. In several cities, large differences were apparent between the age groups. Brighton, Brussels, Lisbon, and Warsaw all reported a difference greater than 20% for the two age groups. Only in Hamburg younger men reported a clearly higher level of this indicator. However, the precision of the estimate for the younger age group is questionable in many cities because the sample sizes were relatively small (<50). Table 1.13 Weighted percentage of MSM who received an HIV test in the past 12 months, 95% confidence intervals, design effect and number of participants, by city and age group (GARPR 1.13). In most cities, HIV prevalence was higher among BARCELONA BRATISLAVA BRIGHTON BRUSSELS BUCHAREST Age Point Estimate 95% Lower Bound 95% Upper Bound Estimated Design Effect Sample Size

13 HAMBURG LISBON LJUBLJANA SOFIA STOCKHOLM VERONA VILNIUS WARSAW

14 Indicator 1.14_ HIV prevalence in men who have sex with men (percentage of men who have sex with men risk who are living with HIV) Weighted HIV prevalence ranged from 10% to 20% in five cities: Brussels, Barcelona, Lisbon, Brighton, and Bucharest; whilst in Hamburg, Warsaw, and Verona it ranged from 5% to 10%. In Stockholm, Vilnius, Ljubljana, Bratislava, and Sofia HIV prevalence was estimated below 5% (see Table 1.14). This distribution across countries reflects the distribution of new HIV diagnoses reported among MSM in 2013 by the ECDC 5, except for Bratislava (Slovakia) that is shown to have a very high rate of new HIV diagnoses in the ECDC report. The highest prevalence was observed in Bucharest: this could, however, be due partially to the RDS recruitment process in that particular study site where specific sub-populations of MSM who inject drugs were enrolled. In most western European cities, the proportion of young MSM aged 25 years in the samples is smaller than in the central/eastern European cities. This has an impact on the precision of the estimates when subgroups disaggregated by age are used. This is evident when the 95% confidence intervals (CIs) are considered together with the prevalence estimates (Table 1.14). In all cities, HIV prevalence was higher among men aged 25 years compared to men aged 25 years, except in Bucharest where it was similar in both groups. The absence of HIV positive participants younger than 25 in Stockholm and Vilnius can be due to the low HIV prevalence and small sample size in these cities. Table 1.14 HIV weighted prevalence among MSM, 95% confidence intervals, design effect and number of participants, by city and age group (GARPR 1.14). In most cities, HIV prevalence was higher among BARCELONA Age Point Estimate 95% Lower Bound 95% Upper Bound Estimated Design Effect Sample Size BRATISLAVA BRIGHTON ECDC HIV/AIDS surveillance in Europe, 2013, available at: b960-af70113dbb90&id=

15 BRUSSELS BUCHAREST HAMBURG LISBON LJUBLJANA SOFIA STOCKHOLM VERONA

16 VILNIUS WARSAW Limitations Sampling methods Two different sampling strategies were used in the SIALON II study: Time Location Sampling in nine cities, and Respondent Driven Sampling in four cities. It has been shown in other studies that these two sampling methods can result in different sample characteristics, and the differences may persist also after applying weighting corrections to the result estimates. Age composition In specific cases, the precision of the estimate for the younger age group is questionable as the sample sizes were relatively small (<50). The proportion of study participants younger than 25 years was larger in central/eastern European than in western European cities. This is most likely explained by the different age structure of the MSM population approachable by surveillance studies. It does probably not reflect a more difficult access to young MSM in Western Europe, but rather a more difficult access to older MSM in central/eastern Europe. Older MSM in central/eastern Europe have grown up in a much more homophobic environment with a lack of gay infrastructure like commercial and non-commercial gay venues. Some of the differences in the GARP indicators between western and central/eastern Europe are associated with these age differences, and also with the different time-points of onset of the HIV epidemic among MSM. Comparability and generalizability of the samples A closer look at behavioural variables in different TLS cities and a comparison with the samples from the same study areas in the European MSM Internet Survey (EMIS) suggests that different segments of the total MSM population were reached in the gay venues which were selected for the recruitment of study participants. For example, gay bars/cafes where gay couples go out for socialising rather than for seeking sex partners are less present in the central/eastern European cities than in the western European cities. This may affect the composition of the relatively small younger age groups ( years) in western European cities, but may also affect the sample from Sofia. While the high self-reported testing rates and scores for the having been reached by prevention indicator are indicative of the good work of the NGO which recruited the participants for the study, this sample is probably less representative for the general MSM population of the study city/country as compared to the TLS samples from other cities. 16

17 Another aspect is the inclusion of tourists from other countries and nationals not residing in the study city in the samples. The proportion of tourists varies considerably between TLS cities, and tourists are nearly absent in the RDS samples. However, since the weighting procedure was based on the frequency of venue visits (less frequent visits are associated with higher weights), tourists may get disproportional high weights which may bias weighted estimates according to the proportion of tourists. 17

18 18

19 19

20 20

21 21

22 22

Table Of Content. Outputs... 10

Table Of Content. Outputs... 10 Table Of Content MEANINGFUL HIV SURVEILLANCE AMONG MSM... 3 Summary... 4 Coordinator, Leader contact and partners... 6 Robert Koch Institute, Berlin... 6 National Institute of Infectious Diseases Prof.

More information

Formative Research results

Formative Research results FRR Annex 5: Presentation of the FR results in the project meeting, Berlin, 11. 13.02.2013 Formative Research results Sandra Dudareva Vizule, Ulrich Marcus Robert Koch Institute 11 February 2013 Content

More information

Sialon : bio-behavioural study among MSM in Brussels and other European cities

Sialon : bio-behavioural study among MSM in Brussels and other European cities Sialon : bio-behavioural study among MSM in Brussels and other European cities Wim Vanden Berghe Christiana Nöstlinger ITM, Antwerp Breach symposium, ITM, Antwerp November 27 th, 2015 Massimo Mirandola,

More information

City Profiles Recommendations on HIV prevention gaps and opportunities for Health Promotion among Men who have Sex with Men

City Profiles Recommendations on HIV prevention gaps and opportunities for Health Promotion among Men who have Sex with Men Recommendations on HIV prevention gaps and opportunities for Health Promotion among Men who have Sex with Men This document is based on data from the Sialon II project, funded under the European Commission

More information

Bio-behavioural study among MSM in European cities. Think Tank Meeting November 25 th, 2015

Bio-behavioural study among MSM in European cities. Think Tank Meeting November 25 th, 2015 Bio-behavioural study among MSM in European cities Think Tank Meeting November 25 th, 2015 Christiana Nöstlinger & Wim Vanden Berghe (WP 8 Prevention) on behalf of the Sialon II Project Group ITM, Antwerp

More information

Report on a Bio-behavioural Survey

Report on a Bio-behavioural Survey Capacity building in combining targeted prevention with meaningful HIV surveillance among MSM Report on a Bio-behavioural Survey among MSM in 13 European cities Cierre Grafica Massimo Mirandola Infectious

More information

Table Of Content. Outputs... 7

Table Of Content. Outputs... 7 Table Of Content CAPACITY BUILDING IN HIV/SYPHILIS PREVALENCE ESTIMATION USING NON-INVASIVE METHODS AMONG MSM IN SOUTHERN AND EASTERN EUROPE... 2 Summary... 3 Coordinator, Leader contact and partners...

More information

WHERE CAN I GET TESTED FOR HIV, SYPHILIS AND OTHER STD (Sexual Transmitted Diseases)?

WHERE CAN I GET TESTED FOR HIV, SYPHILIS AND OTHER STD (Sexual Transmitted Diseases)? Anal sex without a condom is the most risky practice for both you and your partner, even before or without ejaculation, due to possible micro lesions in the rectum and/or on the penis. The overall objective

More information

D7 Prevention Manual and Training

D7 Prevention Manual and Training D7 Prevention Manual and Training Formative Research Report Sandra Dudareva-Vizule, Ulrich Marcus Robert Koch Institut, Berlin Prevention Training Manual Peter de Grot, Wim Vanden Berghe Institut of Tropical

More information

Understanding the spread of HIV among men who have sex with men in Belgium: results from online and on site special surveys

Understanding the spread of HIV among men who have sex with men in Belgium: results from online and on site special surveys Understanding the spread of HIV among men who have sex with men in Belgium: results from online and on site special surveys Wim Vanden Berghe ITM HIV/AIDS center Department of Public Health Institute of

More information

Table Of Content. Outputs... 8

Table Of Content. Outputs... 8 Table Of Content Operational knowledge to improve HIV early diagnosis and treatment among vulnerable groups in Europe... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Društvo Kulturno, informacijsko

More information

HIV/AIDS, STI, hepatitis

HIV/AIDS, STI, hepatitis ECDC update HIV/AIDS, STI, hepatitis HIV EU Think Tank meeting Brussels, 25-26 March 2009 European Centre for Disease Prevention and Control HIV and AIDS surveillance activities Coordination of European-wide

More information

ECDC s role in the fight against HIV/AIDS in Europe

ECDC s role in the fight against HIV/AIDS in Europe European Centre for Disease Prevention and Control ECDC s role in the fight against HIV/AIDS in Europe Marita van de Laar, PhD Program Coordinator HIV/AIDS, STI, hepatitis HIV in Europe, Stockholm, 2 November

More information

Behavioural indicators in men who have sex with men

Behavioural indicators in men who have sex with men Behavioural indicators in men who have sex with men Dr. Brenda Spencer, IUMSP, Lausanne 13 th HIV/AIDS Think Tank Meeting First presented by Prof. Jonathan Elford, City University London European Parliament,

More information

Table Of Content. European Surveillance of Sexually Transmitted Infections... 2 Summary... 3 Coordinator, Leader contact and partners...

Table Of Content. European Surveillance of Sexually Transmitted Infections... 2 Summary... 3 Coordinator, Leader contact and partners... Table Of Content European Surveillance of Sexually Transmitted Infections... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Department of Health and Children/ East Coast Area Health Board...

More information

Table Of Content. The European Influenza Surveillance Scheme... 2 Summary... 3 Coordinator, Leader contact and partners Outputs...

Table Of Content. The European Influenza Surveillance Scheme... 2 Summary... 3 Coordinator, Leader contact and partners Outputs... Table Of Content The European Influenza Surveillance Scheme... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Institut Pasteur... 6 Health Division... 6 Nphs Communicable Disease Surveillance

More information

ECDC and Spanish Ministry of Health workshop:

ECDC and Spanish Ministry of Health workshop: ECDC and Spanish Ministry of Health workshop: Improving the monitoring of HIV among migrant populations in Europe, Madrid, 3-4 October 2013 Teymur Noori EU Commission Thank Tank on HIV/AIDS Luxembourg,

More information

Table Of Content. Outputs... 8

Table Of Content. Outputs... 8 Table Of Content Developing a training and resource package for improving the sexual and reproductive health of people living with HIV/AIDS... 3 Summary... 4 Coordinator, Leader contact and partners...

More information

Health Programme support to the European Action Plan HIV/AIDS

Health Programme support to the European Action Plan HIV/AIDS Health Programme 2008-2013 support to the European Action Plan HIV/AIDS 2009-2012 Executive Agency for Health and Consumers EAHC Cinthia Menel Lemos Cinthia.menel-lemos@ec.europa.eu What are the news?

More information

Policy Brief. 2. The use of UNGASS indicators. 3. Making use of SIALON data

Policy Brief. 2. The use of UNGASS indicators. 3. Making use of SIALON data 2. The use of UNGASS indicators Policy Brief The SIALON Project s objectives are to obtain reliable and valid information on HIV and syphilis prevalence, to study sexual behaviour risk patterns and identify

More information

Steady Ready Go! teady Ready Go. Every day, young people aged years become infected with. Preventing HIV/AIDS in young people

Steady Ready Go! teady Ready Go. Every day, young people aged years become infected with. Preventing HIV/AIDS in young people teady Ready Go y Ready Preventing HIV/AIDS in young people Go Steady Ready Go! Evidence from developing countries on what works A summary of the WHO Technical Report Series No 938 Every day, 5 000 young

More information

HIV/AIDS Joint Action HA-REACT

HIV/AIDS Joint Action HA-REACT HIV/AIDS Joint Action HA-REACT Matthias Schuppe Policy Officer Health Threats Unit DG Health and Food Safety European Commission Policy Framework on HIV/AIDS in EU and neighbouring countries Commission

More information

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods Annual Epidemiological Report for 2015 Trichinellosis Key facts In 2015, a total of 156 confirmed cases of trichinellosis was reported from 29 EU/EEA countries. The overall notification rate was 0.03 cases

More information

Alcohol Prevention Day

Alcohol Prevention Day Alcohol Prevention Day Rome, 16 May 2018 Hana Horka Policy Officer, Unit C4 Health Determinants and International Relations European Commission DG Health and Food Safety (SANTE) Alcohol consumption in

More information

Marcus et al. BMC Infectious Diseases (2017) 17:730 DOI /s x

Marcus et al. BMC Infectious Diseases (2017) 17:730 DOI /s x Marcus et al. BMC Infectious Diseases (2017) 17:730 DOI 10.1186/s12879-017-2814-x RESEARCH ARTICLE HIV serostatus knowledge and serostatus disclosure with the most recent anal intercourse partner in a

More information

Epidemiology of different hepatides (B & C) in Lithuania

Epidemiology of different hepatides (B & C) in Lithuania Epidemiology of different hepatides (B & C) in Lithuania IRMA Čaplinskienė SAULIUS Čaplinskas Head of HIV/AIDS/STI and Hepatitis Surveillance, Centre for Communicable Diseases and AIDS; National ECDC contact

More information

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers HIV and migrants Julia del Amo has received research grants awarded to her institution from Companies BMS, Gilead, ViiV and epidemiology teaching fees from ViiV, Gilead and MSD Dr Julia del Amo National

More information

HIV testing in Europe: From policy to effectiveness

HIV testing in Europe: From policy to effectiveness HIV testing in Europe: From policy to effectiveness 10 th Think Tank meeting Brussels, 9-10 April 2008 Françoise Hamers Scientific Advice Unit, ECDC ecdc.europa.eu Background About 30% of people living

More information

Background Past Present Future

Background Past Present Future Background Past Present Future Background Early testing helps to prevent transmission and lowers the risk of severe health complications Programatic objective: To increase the percentage of HIV + persons

More information

Table Of Content. Improving Quality in HIV Prevention... 3 Summary... 4 Coordinator, Leader contact and partners Outputs...

Table Of Content. Improving Quality in HIV Prevention... 3 Summary... 4 Coordinator, Leader contact and partners Outputs... Table Of Content Improving Quality in HIV Prevention... 3 Summary... 4 Coordinator, Leader contact and partners... 6 Croix-Rouge luxembourgeoise... 6 National Institute for Health Development... 6 MINISTERIO

More information

CNAPA Meeting Luxembourg September 2016

CNAPA Meeting Luxembourg September 2016 CNAPA Meeting Luxembourg September 2016 Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal RARHA Events Policy Dialogue and Final Conference

More information

Mid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006

Mid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006 Mid-term Review of the UNGASS Declaration of Commitment on HIV/AIDS Ireland 2006 Irish Role in Global Response Just as the HIV/AIDS epidemic is a global threat, addressing the challenge of the epidemic

More information

INNOVATIVE PARTNERSHIP FOR ACTION AGAINST CANCER (ipaac) Official ipaac Joint Action presentation

INNOVATIVE PARTNERSHIP FOR ACTION AGAINST CANCER (ipaac) Official ipaac Joint Action presentation INNOVATIVE PARTNERSHIP FOR ACTION AGAINST CANCER (ipaac) GENERAL INFORMATION The Innovative Partnership for Action Against Cancer (ipaac) Joint Action, which has been selected for funding under the Third

More information

COMMISSION OF THE EUROPEAN COMMUNITIES

COMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 22.12.2008 COM(2008) 882 final REPORT FROM THE COMMISSION TO THE COUNCIL, THE EUROPEAN PARLIAMENT, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE

More information

Table Of Content. Outputs... 9

Table Of Content. Outputs... 9 Table Of Content HIV/AIDS and STI-prevention, diagnostic and therapy in crossing border regions among the current and the new EC-outer borders... 2 Summary... 3 Coordinator, Leader contact and partners...

More information

EuroHIV: HIV/AIDS surveillance in Europe

EuroHIV: HIV/AIDS surveillance in Europe EuroHIV 2006 Annual Report (2004203).rev Page 1 of 14 EUROPEAN COMMISSION DG SANCO PROGRAMME OF COMMUNITY ACTION ON THE PREVENTION OF AIDS AND CERTAIN OTHER COMMUNICABLE DISEASES EuroHIV: HIV/AIDS surveillance

More information

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services United Nations Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services Distr.: General 12 July 2011 Original:

More information

Deliverable. Grant Agreement number: Open Access Policy Alignment STrategies for European Union Research. FP7 CAPACITIES Science in Society

Deliverable. Grant Agreement number: Open Access Policy Alignment STrategies for European Union Research. FP7 CAPACITIES Science in Society Deliverable Grant Agreement number: 611742 Project acronym: PASTEUR4OA Project title: Open Access Policy Alignment STrategies for European Union Research Funding Scheme: FP7 CAPACITIES Science in Society

More information

European Guide on Quality Improvement in Comprehensive Cancer Control

European Guide on Quality Improvement in Comprehensive Cancer Control European Guide on Quality Improvement in Comprehensive Cancer Control 13 March 2013, JRC, Ispra Presentation prepared by the National Institute of Public Health of Slovenia OBJECTIVES 1) To identify key

More information

Overview of European Consumption Databases

Overview of European Consumption Databases FEDERAL INSTITUTE FOR RISK ASSESSMENT Overview of European Consumption Databases Katrin Büsch Workshop Food Consumption Data and Dietary Exposure in the European Union, 15-16 May 2008, Berlin Introduction

More information

Table Of Content. Invasive Bacterial Infections Surveillance in the European Union... 2 Summary... 3 Coordinator, Leader contact and partners...

Table Of Content. Invasive Bacterial Infections Surveillance in the European Union... 2 Summary... 3 Coordinator, Leader contact and partners... Table Of Content Invasive Bacterial Infections Surveillance in the European Union... 2 Summary... 3 Coordinator, Leader contact and partners... 5 National School of Public Health... 5 National Institute

More information

World Health Organization. A Sustainable Health Sector

World Health Organization. A Sustainable Health Sector World Health Organization A Sustainable Health Sector Response to HIV Global Health Sector Strategy for HIV/AIDS 2011-2015 (DRAFT OUTLINE FOR CONSULTATION) Version 2.1 15 July 2010 15 July 2010 1 GLOBAL

More information

Updates from the European Centre for Disease Prevention and Control

Updates from the European Centre for Disease Prevention and Control Updates from the European Centre for Disease Prevention and Control AIRA 2018 National Meeting, Salt Lake City Global Perspectives Plenary session Tarik Derrough Senior Expert Vaccine Preventable Diseases

More information

Table Of Content. Outputs... 8

Table Of Content. Outputs... 8 Table Of Content Young and HIV: European network to arrange an innovative prevention campaign and to exchange good practices - experience in Europe"... 2 Summary... 3 Coordinator, Leader contact and partners...

More information

D1: Review of HIV and sexually transmitted infections among men who have sex with men (MSM) in Europe

D1: Review of HIV and sexually transmitted infections among men who have sex with men (MSM) in Europe D1: Review of HIV and sexually transmitted infections among men who have sex with men (MSM) in Europe Work Package 1, ESTICOM Project (European Surveys and Training to Improve MSM Community Health) 1 Prepared

More information

Monthly measles and rubella monitoring report

Monthly measles and rubella monitoring report SURVEILLANCE REPORT Monthly measles and rubella monitoring report December 2018 Period covered: 1 November 2017 to 31 October 2018 Introduction This monitoring report is based on measles and rubella data

More information

ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft)

ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft) ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft) Project Title: HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Project Number: XEEJ20 Total

More information

The SIALON Project: Report on HIV Prevalence and Risk Behaviour Among MSM in Six European Cities

The SIALON Project: Report on HIV Prevalence and Risk Behaviour Among MSM in Six European Cities 11 The SIALON Project: Report on HIV Prevalence and Risk Behaviour Among MSM in Six European Cities Massimo Mirandola et al. * Azienda Ospedaliera Universitaria Integrata Verona (The Hospital Trust of

More information

ROMANIA. Country Progress Report on AIDS Reporting period January 2014 December 2014

ROMANIA. Country Progress Report on AIDS Reporting period January 2014 December 2014 ROMANIA Country Progress Report on AIDS Reporting period January 2014 December 2014 Bucharest, 2015 1 Contents Abbreviations... 3 I. Status at a glance... 4 a) Inclusiveness of stakeholders in the report-writing

More information

Maltese Presidency of the Council of the European Union. Ministry for Health

Maltese Presidency of the Council of the European Union. Ministry for Health Maltese Presidency of the Council of the European Union Ministry for Health The Trio programme Guided by the strategic agenda of the European Council adopted in June 2014 One of the common priority areas

More information

EU Health Programme: working together to improve public health in Europe

EU Health Programme: working together to improve public health in Europe EU HEALTH PROGRAMME EU Health Programme: working together to improve public health in Europe A selection of Public Health Projects with an important impact for EU Member States EUROPEAN COMMISSION The

More information

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Yersiniosis Key facts In 2015, 26 countries reported 7 279 confirmed yersiniosis cases in the EU/EEA. The overall notification rate was 2.0 cases

More information

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal Public Health Public health is the science and art of preventing disease, prolonging

More information

E. Scafato, C. Gandin, L. Galluzzo, S. Ghirini

E. Scafato, C. Gandin, L. Galluzzo, S. Ghirini Drinking guidelines in the context of brief interventions. Results from EU RARHA survey E. Scafato, C. Gandin, L. Galluzzo, S. Ghirini Istituto Superiore di Sanità, Italy WP5: Outline of the work (tasks)

More information

Syphilis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Syphilis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Syphilis Key facts In 2015, 28 701 syphilis cases were reported in 29 EU/EEA Member States (data were not available from Austria and Liechtenstein),

More information

Addressing HIV prevention, care, and research priorities among MSM in Asia

Addressing HIV prevention, care, and research priorities among MSM in Asia Addressing HIV prevention, care, and research priorities among MSM in Asia amfar - The Foundation for AIDS Research Kevin Robert Frost 10 October 2009 Overview The Who - Definitions The What HIV sero-prevalence/incidence

More information

STRATEGIC APPROACH & WORKPLAN 2007

STRATEGIC APPROACH & WORKPLAN 2007 Rare Diseases Europe STRATEGIC APPROACH 2007-2009 & WORKPLAN 2007 Paris, March 2007 www.eurordis.org Contents Our strategic approach 2007 2009 o Eurordis in 2010 o Strategic orientations o Priorities 2007-2009

More information

Groups of young people in Uganda that need to be targeted with HIV interventions

Groups of young people in Uganda that need to be targeted with HIV interventions Module 5: HIV/AIDS and young people - Adolescent health and development with a particular focus on sexual and reproductive health - Assignment Peter James Ibembe Reproductive Health Uganda, Kampala, Uganda

More information

CHRODIS Kick-off. Communication and Dissemination. Cristina Chiotan / Anna Gallinat Public Health Coordinator / Communications Assistant

CHRODIS Kick-off. Communication and Dissemination. Cristina Chiotan / Anna Gallinat Public Health Coordinator / Communications Assistant CHRODIS Kick-off Communication and Dissemination Cristina Chiotan / Anna Gallinat Public Health Coordinator / Communications Assistant EuroHealthNet The European Partnership for improving health, equity

More information

Joint Action on HIV and co-infection prevention and harm reduction HA-REACT

Joint Action on HIV and co-infection prevention and harm reduction HA-REACT Joint Action on HIV and co-infection prevention and harm reduction HA-REACT Principles and challenges of HA-REACT as an example of multilateral and multisectoral programme Mika Salminen, Ph. D, Research

More information

Table Of Content. European surveillance of travel associated legionnaires' disease... 2 Summary... 3 Coordinator, Leader contact and partners...

Table Of Content. European surveillance of travel associated legionnaires' disease... 2 Summary... 3 Coordinator, Leader contact and partners... Table Of Content European surveillance of travel associated legionnaires' disease... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Statens Serum Institute... 5 National Environmental Health

More information

European Partnership for Screening

European Partnership for Screening European Partnership for Screening Lawrence von Karsa Quality Assurance Group European Cancer Network for Screening and Prevention International Agency for Research on Cancer Lyon, France Work Package

More information

Key issues for HIV testing and

Key issues for HIV testing and Key issues for HIV testing and counselling in Europe Martin C Donoghoe Programme Manager HIV/AIDS, STI &Viral Hepatitis Programme WHO Europe Key issues for HIV testing & counselling in Europe HIV epidemics

More information

FAQ IT! : A venue-based HIV prevalence study among Men who have Sex with Men (MSM) in Flanders, Belgium: On methods en ethics

FAQ IT! : A venue-based HIV prevalence study among Men who have Sex with Men (MSM) in Flanders, Belgium: On methods en ethics FAQ IT! : A venue-based HIV prevalence study among Men who have Sex with Men (MSM) in Flanders, Belgium: On methods en ethics Wim Vanden Berghe HIV/STI Epidemiology and Control Unit Department of Microbiology

More information

ECDC update to the EU Commission Think Tank on HIV/AIDS

ECDC update to the EU Commission Think Tank on HIV/AIDS ECDC update to the EU Commission Think Tank on HIV/AIDS Andrew Amato Head of HIV, STI and V. Hepatitis programme, ECDC Luxembourg, 10-11 December 2013 Outline Main ECDC reports published since last Think

More information

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services United Nations Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services Distr.: General 29 September 2011 Original:

More information

On 24 May 2005 the Council (GAERC), in its formation of Development Ministers, adopted the conclusions in Annex I.

On 24 May 2005 the Council (GAERC), in its formation of Development Ministers, adopted the conclusions in Annex I. COUNCIL OF THE EUROPEAN UNION Brussels, 24 May 2005 9278/05 DEVGEN 92 RELEX 257 SAN 74 ONU 61 ACP 73 NOTE from : General Secretariat dated 24 May 2005 No. prev. doc. : 9085/05 DEVGEN 88 RELEX 238 SAN 62

More information

New trends in harm reduction in Europe: progress made challenges ahead

New trends in harm reduction in Europe: progress made challenges ahead New trends in harm reduction in Europe: progress made challenges ahead Dagmar Hedrich, Alessandro Pirona, EMCDDA 2 nd European Harm Reduction Conference, 7-9 May 2014, Basel Session 4: Changes in harm

More information

EUVAC.NET A surveillance network for vaccine-preventable diseases

EUVAC.NET A surveillance network for vaccine-preventable diseases EUVAC.NET A surveillance network for vaccine-preventable diseases Mark Muscat EUVAC.NET Co-ordinator Department of Epidemiology Statens Serum Institut Denmark Email: mmc@ssi.dk Viral Hepatitis Prevention

More information

Jordi Casabona

Jordi Casabona Jordi Casabona jcasabona@iconcologia.net recerca bàsica recerca clínica recerca poblacional Main partner in: Title Partners Funding Period Euro HIV EDAT HIV COBATEST EURO NONOPEP Spain, France, Denmark,

More information

COUNCIL OF THE EUROPEAN UNION. Brussels, 24 November /04 DEVGEN 239 RELEX 575 SAN 190

COUNCIL OF THE EUROPEAN UNION. Brussels, 24 November /04 DEVGEN 239 RELEX 575 SAN 190 COUNCIL OF THE EUROPEAN UNION Brussels, 24 November 2004 15158/04 DEVGEN 239 RELEX 575 SAN 190 NOTE from : the General Secretariat dated : 24 November 2004 No. prev. doc. : 14881/04 DEVGEN 224 RELEX 550

More information

Critical immunity thresholds for measles elimination

Critical immunity thresholds for measles elimination Critical immunity thresholds for measles elimination Sebastian Funk Centre for the Mathematical Modelling of Infectious Diseases London School of Hygiene & Tropical Medicine 19 October, 2017!"vöå"!(}å!öZ&!

More information

The Imp.Ac.T.project. Improving Access to HIV/TB Testing for marginalized groups

The Imp.Ac.T.project. Improving Access to HIV/TB Testing for marginalized groups The Imp.Ac.T.project Improving Access to HIV/TB Testing for marginalized groups Presentation at DRID meeting EMCDDA 11 Oct. 2012 -Jenneke van Ditzhuijzen Acknowledgments: The Project Imp.Ac.T. Improving

More information

Submission Date: 13 April 2010 at: 16:43. Department of Epidemiology

Submission Date: 13 April 2010 at: 16:43. Department of Epidemiology Submission Date: 13 April 2010 at: 16:43 Questionnaire about Institutions partners SECTION 1 Official name 1 1 Provide the name of the organization such as the Ministry of Health or Public Health Institute

More information

THE MULTI-SECTORAL APPROACH TO AIDS CONTROL IN UGANDA EXECUTIVE SUMMARY

THE MULTI-SECTORAL APPROACH TO AIDS CONTROL IN UGANDA EXECUTIVE SUMMARY THE MULTI-SECTORAL APPROACH TO AIDS CONTROL IN UGANDA EXECUTIVE SUMMARY Uganda AIDS Commission February 1993 EXECUTIVE SUMMARY 1. Introduction Background Information to AIDS in Uganda 1. AIDS was first

More information

Shigellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Shigellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods Annual Epidemiological Report for 2016 Shigellosis Key facts Shigellosis is a relatively uncommon disease in the EU/EEA, but remains of concern in some countries and for some population groups. In 2016,

More information

Jordi Casabona CEEISCAT

Jordi Casabona CEEISCAT Jordi Casabona (jcasabona@iconcologia.net) CEEISCAT Purpose : To contribute to promote early HIV diagnosis in Europe by means of improving the implementation, monitoring and evaluation of community-based

More information

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC The Comprehensive Package: The simple truth about our response to drug related HIV Dr. Monica Beg, Signe Rotberga UNODC HIV among injecting drug users Why is it so important? 30% global HIV infections

More information

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS EUROPEAN COMMISSION Brussels, 17.6.011 COM(011) 35 final REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

More information

Measles and rubella monitoring January 2015

Measles and rubella monitoring January 2015 Measles and rubella monitoring January 215 Reporting on January December 214 surveillance data and epidemic intelligence data to the end of January 215 Main developments Measles During the 12-month period

More information

UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision

UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision Updated version following MERG recommendations Context In light of country reports, regional workshops and comments received by a

More information

Screening for hepatitis B and C among migrants in the European Union

Screening for hepatitis B and C among migrants in the European Union Screening for hepatitis B and C among migrants in the European Union Conference on Migrants and Health 12 th May 2016, Lisbon, Portugal Amena Ahmad Hamburg University of Applied Sciences Germany Email:

More information

Action Plan on HIV/AIDS in the EU and neighbouring countries:

Action Plan on HIV/AIDS in the EU and neighbouring countries: Action Plan on HIV/AIDS in the EU and neighbouring countries: 2014-2016 Matthias Schuppe Policy Officer Health Threats Unit DG Health and Consumers European Commission Outline o EU policy framework on

More information

Annex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms)

Annex A: Impact, Outcome and Coverage Indicators (including Glossary of Terms) IMPACT INDICATORS (INDICATORS PER GOAL) HIV/AIDS TUBERCULOSIS MALARIA Reduced HIV prevalence among sexually active population Reduced HIV prevalence in specific groups (sex workers, clients of sex workers,

More information

Operation of the European NGO Network for Smoking Prevention... 2 Summary... 3 Coordinator, Leader contact and partners... 5

Operation of the European NGO Network for Smoking Prevention... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Table Of Content Operation of the European NGO Network for Smoking Prevention... 2 Summary... 3 Coordinator, Leader contact and partners... 5 A.N.P.AS. Associazione Nazionale Pubbliche Assistenze... 5

More information

HIV VCT - concept and practices

HIV VCT - concept and practices European Seminar VOLUNTARY COUNSELING AND TESTING Bucharest, May 30 31, 2008 HIV VCT - concept and practices A comparative assessment among HIV-testing offers in 5 EU countries BORDERNET Project, 2005-2007

More information

NORDIC CONFERENCE ON RARE DISEASES

NORDIC CONFERENCE ON RARE DISEASES www.eurordis.org NORDIC CONFERENCE ON RARE DISEASES 31 May 2012, Reykjavik, Iceland www.eurordis.org RARE DISEASES IN EUROPE Terkel ANDERSEN President of EURORDIS European Organisation for Rare Diseases

More information

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services United Nations DP/FPA/CPD/BRA/5 Executive Board of the United Nations Development Programme, the United Nations Population Fund the United Nations Office for Project Services Distr.: General 26 September

More information

Toolbox for conducting integrated HIV bio-behavioral surveillance (IBBS) in key populations Improving health and reducing inequities worldwide

Toolbox for conducting integrated HIV bio-behavioral surveillance (IBBS) in key populations Improving health and reducing inequities worldwide Toolbox for conducting integrated HIV bio-behavioral surveillance (IBBS) in key populations Improving health and reducing inequities worldwide Copyright The Regents of the University of California, 2014.

More information

NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen

NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, 2011 Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen NDPHS Goals for the HIV/AIDS & AI Expert Group Goal 2: Prevention

More information

Narrative report of HIV Preventive programmes in the Slovak Republic as of 31-st December 2013

Narrative report of HIV Preventive programmes in the Slovak Republic as of 31-st December 2013 Narrative report of HIV Preventive programmes in the Slovak Republic as of 31-st December 2013 1. Introduction HIV/AIDS pandemic is a human, social and economic disaster, with far-reaching implications

More information

Translating Science to end HIV in Latin America and the Caribbean

Translating Science to end HIV in Latin America and the Caribbean Translating Science to end HIV in Latin America and the Caribbean Mexico City, Mexico, 17 th - 18 th and 21 st April www.iasociety.org IAS 2017 post-conference workshop, 17 April 2018 Challenges for PrEP

More information

Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU

Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU Perspectives from regions: successes and challenges in promoting seasonal influenza vaccine usage in the EU N. Safrany European Commission Pr. A. Nicoll ECDC 2 nd WHO GAP mtg 12-14 July 2011 Background

More information

Table Of Content. Outputs... 12

Table Of Content. Outputs... 12 Table Of Content A European Platform For Mental Health Promotion And Mental Disorder Prevention: Indicators, Interventions And Strategies... 2 Summary... 3 Coordinator, Leader contact and partners... 5

More information

Progress in scaling up voluntary medical male circumcision for HIV prevention in East and Southern Africa

Progress in scaling up voluntary medical male circumcision for HIV prevention in East and Southern Africa SUMMARY REPORT Progress in scaling up voluntary medical male circumcision for HIV prevention in East and Southern Africa January December 2012 Table of contents List of acronyms 2 Introduction 3 Summary

More information

HBV-HCV-HIV: THREE DIFFERENT AND SERIOUS THREATS FOR EUROPEAN YOUNG PEOPLE. A NETWORK TO STUDY AND TO FACE THESE CHALLENGES IN EU

HBV-HCV-HIV: THREE DIFFERENT AND SERIOUS THREATS FOR EUROPEAN YOUNG PEOPLE. A NETWORK TO STUDY AND TO FACE THESE CHALLENGES IN EU Table Of Content HBV-HCV-HIV: THREE DIFFERENT AND SERIOUS THREATS FOR EUROPEAN YOUNG PEOPLE. A NETWORK TO STUDY AND TO FACE THESE CHALLENGES IN EU... 3 Summary... 4 Coordinator, Leader contact and partners...

More information

2008 EUROBAROMETER SURVEY ON TOBACCO

2008 EUROBAROMETER SURVEY ON TOBACCO 8 EUROBAROMETER SURVEY ON TOBACCO KEY MSAG Support for smoke-free places: The survey confirms the overwhelming support that smoke-free policies have in the EU. A majority of EU citizens support smoke-free

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL INTERIM REPORT 02_2013

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL INTERIM REPORT 02_2013 EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL EXECUTIVE AGENCY FOR HEALTH AND CONSUMERS Health unit Contract number: 2010 21 02 Acronym: QUANDHIP INTERIM REPORT 02_2013 Proposal title: Quality

More information

H I V b i o - b e h av i o u r a l s u r v e y a m o n g m e n w h o h av e

H I V b i o - b e h av i o u r a l s u r v e y a m o n g m e n w h o h av e R e s e a rc h a r ti cl e s H I V b i o - b e h av i o u r a l s u r v e y a m o n g m e n w h o h av e s e x w i t h m e n i n B a r c e l o n a, B r at i s l ava, B u c h a r e s t, L j u b l j a n

More information

Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012, Luxembourg

Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012, Luxembourg EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C4 - Health determinants Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012,

More information